Multiple Ascending Doses of MEDI6012 in Subjects with Stable Atherosclerotic Cardiovascular Disease

Trial Identifier: D5780C00005
Sponsor: MedImmune, LLC
NCTID:: NCT03004638
Start Date: January 2017
Primary Completion Date: November 2017
Study Completion Date: November 2017
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United States of America, AL Anniston, AL, United States of America, 36207
United States of America, FL Jacksonville, FL, United States of America, 32216
United States of America, FL Port Orange, FL, United States of America, 32127
United States of America, OH Cincinnati, OH, United States of America, 45246